Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects

Drug Development Research

Volumn 51, Issue 2, 2000, Pages 52-65

  Rothman, Richard B ^a   Baumann, Michael H ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Addiction; Anorectics; Dopamine; Feeding; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; AMINOREX; AMPHETAMINE; ANOREXIGENIC AGENT; BRAIN MONOAMINE; CHLORPHENTERMINE; FENFLURAMINE; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; NEW DRUG; NORFENFLURAMINE; PHENETHYLAMINE; PHENTERMINE; SEROTONIN; SODIUM CHLORIDE; TETRODOTOXIN;

CLINICAL TRIAL; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FEEDING BEHAVIOR; HUMAN; MENTAL DISEASE; MONOAMINERGIC SYSTEM; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; OBESITY; PULMONARY HYPERTENSION; REVIEW; SUBSTANCE ABUSE; VALVULAR HEART DISEASE;

EID: 0034517918     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200010)51:2<52::AID-DDR2>3.0.CO;2-H     Document Type: Review

References (5)

1. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B. 1996. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group [see Comments]. N Engl J Med 335:609-616.
2. Amara SG, Kuhar MJ. 1993. Neurotransmitter transporters: recent progress [Review]. Ann Rev Neurosci 16:73-93.
3. Amara SG, Sonders MS. 1998. Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 51:87-96.
4. Atkinson RL, Blank RC, Schumacher D, Dhurandhar NV Ritch DL. 1997. Long-term drug treatment of obesity in a private practice setting. Obes Res 5:578-586.
5. Backmann R, Dengler H, Gahl K, Greiser E, Jesdinsky HJ, Loogen E 1972. [Primary pulmonary hypertension. Report of the Commission of the German Society for Research on Blood Circulation]. Verh Dlsch Ges Kreislaufforsch 38:134-141.